TrialJournal for immunotherapy of cancer2023

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial.

Alex De Caluwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.